Free Trial

Intra-Cellular Therapies (ITCI) SEC Filings & 10K Form

Intra-Cellular Therapies logo
$85.69 +0.24 (+0.28%)
(As of 11/22/2024 ET)

Recent Intra-Cellular Therapies SEC Filings

DateFilerForm TypeView
11/14/2024
5:01 PM
Halstead Michael (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2024
6:10 AM
Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2024
6:44 AM
Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2024
6:53 AM
Intra-Cellular Therapies (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/24/2024
1:02 PM
BlackRock, Inc. (Filed by)
Intra-Cellular Therapies (Subject)
Form SC 13G/A
10/15/2024
5:00 PM
Intra-Cellular Therapies (Issuer)
RIGGS RORY B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/10/2024
11:36 AM
Intra-Cellular Therapies (Subject)
JPMORGAN CHASE & CO (Filed by)
JPMORGAN CHASE & CO (Filed by)
Form SC 13G
10/02/2024
5:01 PM
Intra-Cellular Therapies (Issuer)
RIGGS RORY B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2024
4:43 PM
Alexandria Venture Investments, LLC (Reporting)
Intra-Cellular Therapies (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/30/2024
5:01 PM
Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/30/2024
3:06 PM
Intra-Cellular Therapies (Subject)
Mates Sharon (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/29/2024
3:34 PM
Intra-Cellular Therapies (Subject)
Mates Sharon (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/28/2024
5:00 PM
Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/28/2024
3:34 PM
Intra-Cellular Therapies (Subject)
Mates Sharon (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/26/2024
3:36 PM
Intra-Cellular Therapies (Subject)
Mates Sharon (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/23/2024
5:00 PM
Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
3:09 PM
Intra-Cellular Therapies (Subject)
Mates Sharon (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/20/2024
5:03 PM
Intra-Cellular Therapies (Issuer)
Neumann Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
5:00 PM
Intra-Cellular Therapies (Issuer)
Narula Sanjeev (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/14/2024
5:01 PM
Intra-Cellular Therapies (Issuer)
Narula Sanjeev (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2024
6:55 AM
Intra-Cellular Therapies (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/07/2024
6:49 AM
Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/02/2024
7:00 PM
Intra-Cellular Therapies (Issuer)
RIGGS RORY B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
7:00 PM
Intra-Cellular Therapies (Issuer)
VAN NOSTRAND ROBERT L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
5:04 PM
Intra-Cellular Therapies (Issuer)
RIGGS RORY B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
5:05 PM
Intra-Cellular Therapies (Issuer)
MARCUS JOEL S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
5:05 PM
Intra-Cellular Therapies (Issuer)
Salas Eduardo Rene (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
5:05 PM
Intra-Cellular Therapies (Issuer)
VAN NOSTRAND ROBERT L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
3:28 PM
Intra-Cellular Therapies (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/21/2024
5:00 PM
Intra-Cellular Therapies (Issuer)
VAN NOSTRAND ROBERT L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
5:00 PM
Intra-Cellular Therapies (Issuer)
VAN NOSTRAND ROBERT L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
5:01 PM
Intra-Cellular Therapies (Issuer)
MARCUS JOEL S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
5:02 PM
Intra-Cellular Therapies (Issuer)
RIGGS RORY B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
5:02 PM
Intra-Cellular Therapies (Issuer)
Salas Eduardo Rene (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
6:37 AM
Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2024
6:40 AM
Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2024
6:43 AM
Intra-Cellular Therapies (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/29/2024
3:46 PM
Intra-Cellular Therapies (Filer)
Form DEFA14A
04/29/2024
3:48 PM
Intra-Cellular Therapies (Filer)
Form ARS
04/24/2024
3:20 PM
Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/18/2024
4:23 PM
Intra-Cellular Therapies (Filer)
Form 424B5
[625,000% Gain] – Are You Ready for the Next Altcoin Boom? (Ad)

All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.

Register for the FREE Workshop Now & get $10 in Bitcoin
04/18/2024
4:25 PM
Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/16/2024
3:40 PM
Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/16/2024
3:37 PM
Intra-Cellular Therapies (Filer)
Form 424B5
04/16/2024
6:10 AM
Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/02/2024
3:15 PM
Intra-Cellular Therapies (Issuer)
RIGGS RORY B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
3:15 PM
Intra-Cellular Therapies (Issuer)
VAN NOSTRAND ROBERT L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2024
4:15 PM
Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/19/2024
7:44 AM
Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/11/2024
7:31 PM
Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
7:31 PM
Intra-Cellular Therapies (Issuer)
Neumann Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
7:32 PM
Halstead Michael (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
7:33 PM
Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
7:33 PM
Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
3:52 PM
Intra-Cellular Therapies (Subject)
Neumann Mark (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/11/2024
3:38 PM
Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/11/2024
3:45 PM
Halstead Michael (Reporting)
Intra-Cellular Therapies (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/11/2024
3:30 PM
Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/11/2024
3:30 PM
Intra-Cellular Therapies (Subject)
Mates Sharon (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/08/2024
4:58 PM
Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
4:58 PM
Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
4:58 PM
Halstead Michael (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
4:59 PM
Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
4:59 PM
Intra-Cellular Therapies (Issuer)
Neumann Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
3:44 PM
Intra-Cellular Therapies (Subject)
Neumann Mark (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/07/2024
3:36 PM
Halstead Michael (Reporting)
Intra-Cellular Therapies (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/07/2024
3:27 PM
Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/05/2024
6:04 PM
Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
6:05 PM
Intra-Cellular Therapies (Issuer)
Neumann Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
6:05 PM
Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
6:05 PM
Halstead Michael (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
6:41 PM
Intra-Cellular Therapies (Issuer)
VAN NOSTRAND ROBERT L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
6:57 PM
Intra-Cellular Therapies (Issuer)
MARCUS JOEL S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
6:58 PM
Intra-Cellular Therapies (Issuer)
Neumann Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
6:58 PM
Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
6:59 PM
Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
7:00 PM
Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
7:00 PM
Halstead Michael (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
3:22 PM
Intra-Cellular Therapies (Subject)
VAN NOSTRAND ROBERT L (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/26/2024
3:46 PM
Halstead Michael (Reporting)
Intra-Cellular Therapies (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/26/2024
3:46 PM
Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/26/2024
3:33 PM
Intra-Cellular Therapies (Subject)
Mates Sharon (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/26/2024
3:22 PM
Intra-Cellular Therapies (Subject)
Neumann Mark (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/22/2024
6:39 AM
Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/22/2024
6:42 AM
Intra-Cellular Therapies (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/09/2024
11:40 AM
Intra-Cellular Therapies (Subject)
WASATCH ADVISORS LP (Filed by)
Form SC 13G/A
02/05/2024
5:02 PM
Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
5:05 PM
Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
5:07 PM
Intra-Cellular Therapies (Issuer)
Neumann Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
5:10 PM
Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
5:13 PM
Halstead Michael (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Trump won. Buy this coin now. (Ad)

Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.

02/02/2024
3:47 PM
Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/02/2024
3:39 PM
Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/02/2024
3:41 PM
Intra-Cellular Therapies (Subject)
Mates Sharon (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/18/2024
6:47 PM
Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2024
4:08 PM
Intra-Cellular Therapies (Subject)
Mates Sharon (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/12/2024
5:02 PM
Halstead Michael (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2024
3:45 PM
Halstead Michael (Reporting)
Intra-Cellular Therapies (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/04/2024
6:54 PM
Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
5:43 PM
Intra-Cellular Therapies (Issuer)
VAN NOSTRAND ROBERT L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:ITCI) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners